BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4046540)

  • 1. [Effectiveness of immunocorrective therapy of recurrent erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Klin Med (Mosk); 1985 Jul; 63(7):69-73. PubMed ID: 4046540
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with the clinical use of methyluracil, sodium nucleinate and levamisole in the complex treatment of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Vrach Delo; 1983 Oct; (10):102-6. PubMed ID: 6359683
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of a sodium nucleinate and levamisole combination on the effectiveness of antibiotic therapy and bicillin prophylaxis of erysipelas recurrences].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiot Med Biotekhnol; 1987 May; 32(5):379-82. PubMed ID: 3606056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunomodulating therapy of middle-aged and elderly patients with erysipelas].
    Frolov VM; Rychnev VE; Razenkova AT; Baskakov IN; Gurina AA
    Vrach Delo; 1987 Jul; (7):103-5. PubMed ID: 3630100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative effectiveness of decaris and saparal in recurrent peptic ulcer].
    Tsimmerman IaS; Golovanova ES; Romanova ZhN
    Sov Med; 1989; (10):88-91. PubMed ID: 2694385
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of sodium nucleinate on the effectiveness of antibiotic therapy of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiotiki; 1984 Feb; 29(2):132-5. PubMed ID: 6703667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinico-pathogenetic substantiation of the immunocorrective treatment of pyelonephritis in infants].
    Kirillov VI
    Pediatriia; 1990; (2):24-31. PubMed ID: 2349036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levamisole and its use in dermatologic therapy].
    Marcyniak-Górska M
    Przegl Dermatol; 1983; 70(5-6):563-8. PubMed ID: 6366926
    [No Abstract]   [Full Text] [Related]  

  • 9. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of bemitil in recurrent erysipelas].
    Ratnikova LI
    Klin Med (Mosk); 1991 Jul; 69(7):89-90. PubMed ID: 1942990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effectiveness of the use of zaditen and leakadin in recurrent erysipelas].
    Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN; Pustovoĭ IuG
    Ross Med Zh; 1992; (3):38-9. PubMed ID: 1643358
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary immunodeficiency states and their correction with sodium nucleinate].
    Zemskov AM; Perediriĭ VG; Zemskov VM; Provotorov VM; Nikitin AV
    Ter Arkh; 1982; 54(4):55-8. PubMed ID: 7101158
    [No Abstract]   [Full Text] [Related]  

  • 14. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sodium nucleinate as a modulator of secondary immunological insufficiency and dysnucleotidosis in nonspecific inflammatory lung diseases].
    Zemskov AM; Zemskov VM; Nikitin AV
    Ter Arkh; 1993; 65(5):87-91. PubMed ID: 8036607
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of various programs of immunocorrective therapy in chronic infectious-inflammatory diseases].
    Gordienko SM; Lozovoĭ VP; Avdiunicheva OE; Kozlov VA
    Ter Arkh; 1986; 58(4):86-9. PubMed ID: 3715763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for levamisole therapy of infectious inflammatory lung diseases].
    Komarov FI; Chuchalin AG; Daniliak IG; Pavlova EA; Dunaeva TP
    Ter Arkh; 1981; 53(3):65-70. PubMed ID: 7256615
    [No Abstract]   [Full Text] [Related]  

  • 18. [Principles of a differentiated immunocorrective therapy].
    Perederiĭ VG; Zemskov AM
    Vrach Delo; 1988 Aug; (8):71-4. PubMed ID: 3264643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness in treating patients with different clinical forms of erysipelas].
    Kriukova ZV; Kriukova SA; Panichkina LN
    Vrach Delo; 1986 Aug; (8):121-2. PubMed ID: 3776149
    [No Abstract]   [Full Text] [Related]  

  • 20. Levamisole as an immunostimulant.
    Pár A
    Ther Hung; 1980; 28(4):163-7. PubMed ID: 6782693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.